Hubei Humanwell Pharmaceutical Excipients Co., Ltd.

It proposes the strategic positioning of Service Provider of Functional Capsules, and has developed a series of functional capsules such as HPMC 2.0, Shatterproof Capsule, Immediate Release Capsule, and Slowly Crosslinked Capsule. It has technical solutions that do not contain titanium dioxide and sodium dodecyl sulfate in line with the international regulations. Not sterilized by ethylene oxide, without adding preservatives, HumanwellCaps capsules can better meet customers' personalized and innovative preparation needs. At present, HumanwellCaps capsules have been exported to more than *0 countries and regions in Europe, America, Southeast Asia, Africa, etc., providing high-quality capsules and customized solutions for global customers. 

In ***4, HumanwellCaps will move to the new smart campus with a total investment of 1 billion yuan. Based on the principle of High-Standard Planning, High-Starting-Point Construction, High-Quality Management and High-Efficiency Operation, a world-class research institute of pharmaceutical excipients, intelligent workshops, and the supporting offices have been established. As a partner in the development stage of HumanwellCaps, IBM will facilitate HumanwellCaps to accelerate the digital transformation, to build an international and intelligent green factory, and strive to become a benchmark enterprise in the global pharmaceutical excipients segmentation field.